Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:BIOA

(BIOA) (BIOA) Stock Price, News & Analysis

(BIOA) logo

About (BIOA) Stock (NYSE:BIOA)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$4.40
$5.00
50-Day Range
N/A
52-Week Range
$3.80
$26.62
Volume
512,188 shs
Average Volume
540,070 shs
Market Capitalization
$136.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.67
Consensus Rating
Reduce

Company Overview

BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

Remove Ads
Receive BIOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BIOA) and its competitors with MarketBeat's FREE daily newsletter.

BIOA Stock News Headlines

Jefferies Reaffirms Their Hold Rating on BioAge Labs, Inc. (BIOA)
Do this Before Elon's Reveal on April 23rd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
See More Headlines

BIOA Stock Analysis - Frequently Asked Questions

(BIOA) (NYSE:BIOA) released its quarterly earnings data on Thursday, November, 7th. The biotechnology company reported ($6.70) EPS for the quarter, missing analysts' consensus estimates of ($0.62) by $6.08.

(BIOA) (BIOA) raised $198 million in an initial public offering on Thursday, September 26th 2024. The company issued 11,000,000 shares at a price of $18.00 per share.

(BIOA)'s lock-up period expired on Tuesday, March 25th. (BIOA) had issued 11,000,000 shares in its IPO on September 26th. The total size of the offering was $198,000,000 based on an initial share price of $18.00. Since the expiration of (BIOA)'s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Top institutional shareholders of (BIOA) include AH Capital Management L.L.C. (9.02%), Suvretta Capital Management LLC (4.05%), Tang Capital Management LLC (3.68%) and RA Capital Management L.P. (3.66%). Insiders that own company stock include Vijay Satyanand Pande and Shane Barton.
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that (BIOA) investors own include ProQR Therapeutics (PRQR), Flexion Therapeutics (FLXN), Rite Aid (RAD), LadRx (CYTR), Intellipharmaceutics International (IPCIF), NVIDIA (NVDA) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/07/2024
Today
3/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:BIOA
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.67
High Stock Price Target
$7.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+48.3%
Consensus Rating
Reduce
Rating Score (0-4)
1.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$136.95 million
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NYSE:BIOA) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners